Innate Pharma
IPHA
#7872
Rank
ยฃ0.14 B
Marketcap
ยฃ1.71
Share price
1.81%
Change (1 day)
-24.94%
Change (1 year)

Revenue for Innate Pharma (IPHA)

Revenue in 2022: ยฃ40.52 M

According to Innate Pharma 's latest financial reports the company's current revenue (TTM) is ยฃ40.52 M. In 2022 the company made a revenue of ยฃ40.52 M an increase over the revenue in the year 2021 that were of ยฃ10.49 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Innate Pharma from 2005 to 2022

Annual revenue

Year Revenue Change
2022ยฃ40.52 M286.02%
2021ยฃ10.49 M-79.93%
2020ยฃ52.3 M-10.89%
2019ยฃ58.69 M-15.83%
2018ยฃ69.73 M133.75%
2017ยฃ29.83 M-33.72%
2016ยฃ45.01 M202.19%
2015ยฃ14.89 M1670.5%
2014ยฃ0.84 M-93.59%
2013ยฃ13.12 M25.6%
2012ยฃ10.45 M41.68%
2011ยฃ7.37 M68.89%
2010ยฃ4.36 M-48.11%
2009ยฃ8.41 M-39.42%
2008ยฃ13.89 M-13.45%
2007ยฃ16.05 M88.35%
2006ยฃ8.52 M286.35%
2005ยฃ2.2 M